Casey M. Theriot - Concepedia

Author

Casey M. Theriot

Also Known As

C. M. Theriot, C.M. Theriot, Casey M Theriot, Casey M. Theriot, Casey Theriot, Dorrestein, Pieter C., Montgomery, Stephanie A., Theriot, Casey M.

105

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

North Carolina State University University of Michigan University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center North Central State College

About

Casey M. Theriot is an author at North Carolina State University specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	2.7K
2	Health Sciences	4	4	844
3	Natural Sciences	3	3	117
4	Public Health	1	1	215
5	Allergy	1	1	23

Casey M. Theriot

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells Chi Ma, Miaojun Han, Bernd Heinrich, Science	2018	1.4K
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection Casey M. Theriot, Mark J. Koenigsknecht, Paul E. Carlson, Nature Communications DysbiosisAntibioticsGut MicrobiologyMetabolome Increase SusceptibilityMouse Gut Microbiome	2014	964
High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution Benjamin J. Callahan, Joan Wong, Cheryl Heiner, Nucleic Acids Research	2019	641
Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine Casey M. Theriot, Alison A. Bowman, Vincent B. Young mSphere DysbiosisAntibiotic-induced AlterationsDigestive TractAnaerobic CulturingGut Microbiology	2016	474
The interplay between microbiome dynamics and pathogen dynamics in a murine model of<i>Clostridium difficile</i>Infection Angela E. Reeves, Casey M. Theriot, Ingrid L. Bergin, Gut Microbes DysbiosisMicrobial PathogensAntibiotic ResistanceBacterial PathogensClostridium Difficile Infection	2011	279
Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract Matthew H. Foley, Sarah O’Flaherty, Rodolphe Barrangou, PLoS Pathogens	2019	248
Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids Rajani Thanissery, Jenessa A. Winston, Casey M. Theriot Anaerobe DysbiosisBiliary TractSpore GerminationSecondary Bile AcidsGut Microbiota	2017	237
Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation Cecilia Noecker, Alexander Eng, Sujatha Srinivasan, mSystems DysbiosisMicrobial MetabolismMetabolic VariationMetabolic ModelMetabolic Network	2016	215
Cefoperazone-treated mice as an experimental platform to assess differential virulence of<i>Clostridium difficile</i>strains Casey M. Theriot, Charles C. Koumpouras, Paul E. Carlson, Gut Microbes	2011	205
<i>In Vivo</i> Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials Kurt Selle, Joshua R. Fletcher, Hannah H. Tuson, mBio	2020	205

Page 1